Literature DB >> 15492969

The hypothalamic-pituitary axis in men and women with chronic kidney disease.

Jean L Holley1.   

Abstract

Although the precise abnormalities that lead to failure of the hypothalamic-pituitary-gonadal axis in men and women with chronic kidney disease (CKD) and end-stage renal disease (ESRD) remains undefined, evidence exists for defects in both the hypothalamus and the pituitary. The lack of appropriate cyclic release of gonadotropin-releasing hormone (GnRH) by the hypothalamus leads to loss of normal pulsatile luteinizing hormone (LH) release by the pituitary, which results in impaired ovulation in women and reduced testosterone and sperm production in men. The cause of impaired cyclic release of GnRH is unclear, but hyperprolactinemia, elevated endorphins, and high levels of GnRH and LH caused by reduced clearance may contribute. Perturbations of the hypothalamic-pituitary-gonadaotropin axis in CKD lead to high rates of infertility, dysfunctional uterine bleeding, and impaired puberty in children. Only through additional study of the complex effects of CKD on the hypothalamic-pituitary-gonadal axis will the precise abnormalities in hormonal control of reproduction be explained.

Entities:  

Mesh:

Year:  2004        PMID: 15492969

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  23 in total

Review 1.  Biochemical diagnosis in prolactinomas: some caveats.

Authors:  Stephan Petersenn
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

2.  Quantitative in vivo 23Na MR imaging of the healthy human kidney: determination of physiological ranges at 3.0T with comparison to DWI and BOLD.

Authors:  Stefan Haneder; Paul Kettnaker; Simon Konstandin; John N Morelli; Lothar R Schad; Stefan O Schoenberg; Henrik J Michaely
Journal:  MAGMA       Date:  2013-03-09       Impact factor: 2.310

3.  Ovarian reserve in an Egyptian cohort with end-stage kidney disease on hemodialysis and after successful kidney transplantation: a prospective study.

Authors:  Ahmed Fayed; Ahmed Soliman; Mervat Naguib; Mahmoud Soliman; M Salaheldin
Journal:  Int Urol Nephrol       Date:  2019-02-08       Impact factor: 2.370

4.  Hyperprolactinemia as a prognostic factor for menstrual disorders in female adolescents with advanced chronic kidney disease.

Authors:  Juana Serret-Montaya; Jessie N Zurita-Cruz; Miguel A Villasís-Keever; Alejandra Aguilar-Kitsu; Claudia Del Carmen Zepeda-Martinez; Irving Cruz-Anleu; Beatriz C Hernández-Hernández; Sara R Alonso-Flores; Leticia Manuel-Apolinar; Leticia Damasio-Santana; Abigail Hernandez-Cabezza; José C Romo-Vázquez
Journal:  Pediatr Nephrol       Date:  2020-02-10       Impact factor: 3.714

5.  Subfertility and early menopause in women with glomerular disease.

Authors:  Monica L Reynolds; Caroline J Poulton; Lauren N Blazek; Susan L Hogan; Ronald J Falk; Vimal K Derebail
Journal:  Nephrol Dial Transplant       Date:  2021-04-26       Impact factor: 5.992

Review 6.  The effect of frailty should be considered in the management plan of older people with Type 2 diabetes.

Authors:  Ahmed H Abdelhafiz; Luan Koay; Alan J Sinclair
Journal:  Future Sci OA       Date:  2016-02-12

Review 7.  Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients.

Authors:  Grace Snyder; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2016-12

8.  The Association of Posttraumatic Stress Disorder With Longitudinal Change in Glomerular Filtration Rate in World Trade Center Responders.

Authors:  Farrukh M Koraishy; Steven G Coca; Beth E Cohen; Jeffery F Scherrer; Frank Mann; Pei-Fen Kuan; Benjamin J Luft; Sean A P Clouston
Journal:  Psychosom Med       Date:  2021 Nov-Dec 01       Impact factor: 4.312

9.  The impact of nocturnal hemodialysis on sexual function.

Authors:  Adam Bass; Sofia B Ahmed; Scott Klarenbach; Bruce Culleton; Brenda R Hemmelgarn; Braden Manns
Journal:  BMC Nephrol       Date:  2012-07-26       Impact factor: 2.388

10.  Testosterone and gonadotropins but not SHBG vary with CKD stages in young and middle aged men.

Authors:  Britta Hylander; Mikael Lehtihet
Journal:  Basic Clin Androl       Date:  2015-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.